INDOUS vs KOTARISUG: Stock Comparison

Indo Us Biotech Limited vs Kothari Sugars And Chemicals Limited

Live data: 24 July 2026, 4:08 PM IST • Source: NSE and company filings

Kothari Sugars And Chemicals Limited is the larger company by market capitalisation. Indo Us Biotech Limited shows a higher ROE, a higher dividend yield and lower leverage, while Kothari Sugars And Chemicals Limited shows faster revenue growth. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Side-by-side comparison of Indo Us Biotech Limited and Kothari Sugars And Chemicals Limited on live price, valuation, growth, profitability, leverage and quarterly shareholding. Highlighted values mark the more favourable of the two on that metric's usual reading; a single metric is never the full story.

On standard readings, INDOUS is more favourable on 7 of 11 scored metrics and KOTARISUG on 2These counts are context-free and are not an overall rating.

Key Differences

Market Cap
KOTARISUG is the larger company
₹203 Cr vs ₹170 Cr
EPS
INDOUS has higher earnings per share
₹6.54 vs ₹0.8
Dividend Yield
INDOUS has a higher dividend yield
0.29% vs 0%
Revenue Growth (TTM YoY)
KOTARISUG has faster revenue growth
16.4% vs -22%
EPS Growth (TTM YoY)
KOTARISUG has faster EPS growth
0% vs -47.3%
ROE
INDOUS has a higher ROE
16.9% vs 5.27%
ROCE
INDOUS has a higher ROCE
15.4% vs 7.65%
Net Margin
INDOUS has a higher net margin
11.88% vs -0.1%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricINDOUSKOTARISUG
SectorFast Moving Consumer GoodsFast Moving Consumer Goods
IndustryOther Agricultural ProductsSugar

Price

MetricINDOUSKOTARISUG
Live Price₹84.98₹24.45
Day Change-2.24%-0.93%
Volume17,31145,876
52-Week High₹182.1₹37.68
52-Week Low₹84.91₹22.5
Distance from 52W High-53.33%-35.11%

Valuation

MetricINDOUSKOTARISUG
Market Cap₹170 Cr₹203 Cr
P/E Ratio0x0x
P/B Ratio0x0x
EPS₹6.54₹0.8
Book Value₹45.99₹37.42
Dividend Yield0.29%0%

Growth

MetricINDOUSKOTARISUG
Revenue Growth (TTM YoY)-22%16.4%
EPS Growth (TTM YoY)-47.3%0%
Qtr Sales Growth5.64%
Qtr Profit Growth-24%

Profitability & Leverage

MetricINDOUSKOTARISUG
ROE16.9%5.27%
ROCE15.4%7.65%
Net Margin11.88%-0.1%
Operating Margin13.8%9.67%
Debt to Equity0.33x0.86x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricINDOUSKOTARISUG
Promoter Holding68.29%73.53%
FII Holding0.01% 0.17 pp0.15% 0.01 pp
DII Holding0.49%
Public Holding31.7% 0.17 pp25.81% 0.01 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: Indo Us Biotech Limited and Kothari Sugars And Chemicals Limited.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.